Praxis Precision Medicines, Inc.
PRAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9 | $2 | $0 | $0 |
| % Growth | 249.5% | – | – | – |
| Cost of Goods Sold | $152 | $87 | $154 | $0 |
| Gross Profit | -$144 | -$84 | -$154 | $0 |
| % Margin | -1,682% | -3,445.8% | – | – |
| R&D Expenses | $152 | $87 | $155 | $120 |
| G&A Expenses | $56 | $42 | $60 | $47 |
| SG&A Expenses | $56 | $42 | $60 | $47 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$152 | -$87 | -$154 | $0 |
| Operating Expenses | $56 | $42 | $61 | $167 |
| Operating Income | -$200 | -$126 | -$215 | -$167 |
| % Margin | -2,340.3% | -5,164.4% | – | – |
| Other Income/Exp. Net | $17 | $3 | $1 | $0 |
| Pre-Tax Income | -$183 | -$123 | -$214 | -$167 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$183 | -$123 | -$214 | -$167 |
| % Margin | -2,137.5% | -5,037.9% | – | – |
| EPS | -10.21 | -18.69 | -69.33 | -58.96 |
| % Growth | 45.4% | 73% | -17.6% | – |
| EPS Diluted | -10.21 | -18.69 | -69.33 | -58.96 |
| Weighted Avg Shares Out | 18 | 7 | 3 | 3 |
| Weighted Avg Shares Out Dil | 18 | 7 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $17 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$200 | -$126 | -$214 | -$167 |
| % Margin | -2,336.1% | -5,146.8% | – | – |